Mitochondria as targets for established and novel anti-cancer agents
Abstract:
Chemoresistant cells have acquired the ability to evade the action of multiple classes of anti-neoplastic compounds. One mechanism by which tumor cells survive in the presence of chemotherapy is by increasing their apoptotic threshold. Since mitochondria are central players in drug-induced apoptosis, recent efforts to eradicate chemorefractory cells have focused on the identification of compounds that directly affect mitochondrial function. A number of reports indicate that mitochondria are direct targets for multiple classes of experimental compounds. A few clinically available anticancer agents like DNA damaging compounds and anti-microtubule agents are also reported to act directly on mitochondria. The purpose of this mini-review is to discuss recent advances in the interactions between anti-cancer agents and mitochondria, and highlight potential mitochondrial targets for novel chemotherapeutic interventions.
Insights
Chemoresistant cancer cells evade chemotherapy by raising their apoptotic threshold. Targeting mitochondria, central to drug-induced apoptosis, offers a promising strategy for novel cancer therapies.
Area of Science:
- Oncology
- Mitochondrial Biology
- Pharmacology
Background:
- Chemoresistant cells evade anti-neoplastic drugs by increasing apoptosis resistance.
- Mitochondria are key mediators of chemotherapy-induced apoptosis.
- Targeting mitochondria is a strategy to overcome chemoresistance.
Purpose of the Study:
- Review recent advances in anti-cancer agent interactions with mitochondria.
- Highlight potential mitochondrial targets for novel chemotherapeutic interventions.
Main Methods:
- Literature review of studies on anti-cancer agents and mitochondria.
- Analysis of experimental and clinical data on mitochondrial drug targets.
Main Results:
- Mitochondria are direct targets for various experimental anti-cancer compounds.
- Clinically used agents like DNA damaging and anti-microtubule drugs also affect mitochondria.
- Evidence supports mitochondria as crucial sites for anti-cancer drug action.
Conclusions:
- Mitochondrial-targeted therapies hold potential for overcoming chemoresistance.
- Further research into novel mitochondrial targets could lead to more effective cancer treatments.
More Related Videos
Related Concept Videos
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:31Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
01:27Tumor Immunotherapy